期刊名称:ONCOGENE
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and Scope: Oncogene covers all aspects of the structure and function of oncogenes, in particular: cellular oncogenes and their mechanism of activation; structure and function of their encoded proteins; oncogenes of the DNA and the RNA tumor viruses; the molecular oncology of human tumors; tumor suppressor genes; growth regulatory genes; cell cycle control; growth factors and receptors; apoptosis.
Oncogene Reviews: These issues are specially commissioned by the editors and include reviews on topics of particular current interest. |
|
Readership: All researchers interested in the molecular biology of malignant change including molecular biologists, cell biologists, oncologists, geneticists and biotechnologists. |
|
Abstracted in: Elsevier BIOBASE/Current Awareness in Biological Sciences, Current Contents, EMBASE/Excerpta Medica, Research Alert, Science Citation Index, Index Medicus/MEDLINE, BIOSIS, SciSearch, Biotechnology Citation Index. |
Instructions to Authors
Submission of Manuscripts
A manuscript (including figures) should be submitted either
- directly to the US office by using the new online system available from http://mts-onc.nature.com. Detailed instructions for authors submitting online are also available at this website. Correspondence for manuscripts submitted online should be sent to oncogene@assetpublishing.net
- the British Editorial Office (click here for address), or
- two copies may be submitted directly to an editorial board member who will arrange for refereeing. In this case the top copy should be submitted directly to the British Editorial Office with a copy of the covering letter sent to the editorial board member. For authors submitting directly to Dr T Rabbitts please send four copies of your manuscript.
Copyright
Authors will be asked before publication to assign the world copyright of their manuscript to Nature Publishing Group. Therefore, all manuscripts submitted must be accompanied by a signed statement that the article is original, is not under consideration or has not been previously published elsewhere and its content has not been anticipated by any previous publication. Authors will be entitled to publish any part of their paper elsewhere without permission, provided the usual acknowledgements are given. The assignment of copyright will not affect subsisting patent rights or arrangements relating to them. Submission of a manuscript will be taken to imply that authors have obtained permission from their employers or institution to publish, if they have a contractual or moral obligation to do so.
Proofs
A PDF of your page proof will be emailed to you together with copyright and offprint order forms. Instructions on how to return the forms and corrections accompany the proof. Proofs must be checked and returned immediately by the swiftest method available together with the completed forms. Extensive changes to the proof will result in publication delay and all costs incurred will be charged to the author.
Preparation of Manuscripts
All manuscripts should be in English. Please ensure that the manuscripts are well presented and that grammar, spelling and punctuation are checked. The original and two copies of the manuscript should be legibly typed on A4 or American quarto paper. All sections of the manuscript must be double-spaced with generous margins. Number each page, including the title page. Underline only words or letters to appear in italics. Please indicate the position of each figure and table in the margin.
Short Reports Manuscripts with four display items or less should be prepared as Short Communications, comprising a title page, abstract, main text, acknowledgements, references, tables and legends to figures. Please note that the text should not be subdivided into Introduction, Results and Discussion sections, and that all Materials and methods should be included in the figure legends. The text (including references and figure legends) should be succinctly written, and figures prepared to occupy a minimum of space. In general, Short Communications should not exceed four pages of the journal in their final printed form; therefore please aim for a word total (including references and legends) of 3000 or less.
Full Papers Manuscripts with more than four display items should be subdivided into the following sequence of sections: Title page, Abstract, Introduction, Results sections, Discussion, Materials and methods, Acknowledgements, References, Tables, Legends to figures. Please keep the text as brief and clear as possible, and prepare figures to occupy a minimum of space. In general, full-length papers should not exceed 7 pages of the journal in their final printed form; therefore please aim for a word total (including references and figure legends) of 5000 or less.
Title Page The title should be short and to the point. The surname and initials of each author should be followed by his or her department, institution, city with postal code and country. Any changes of address may be given in numbered footnotes. The author(s) to whom proofs are to be addressed should be indicated. Please provide a running title of not more than 50 characters and from 3 to 6 keywords. Make sure that the manuscript has a contact telephone number on it.
Abstract The second page of every manuscript must contain only the abstract, which should be a single paragraph not exceeding 200 words. Please abide strictly by this limitation of length. The abstract should be comprehensive to readers before they have read the paper, and abbreviations and reference citations should be avoided.
Acknowledgements These should be included at the end of the text and not in footnotes. Personal acknowledgements should precede those of institutions or agencies.
References Authors are responsible for the accuracy of references. Articles in the press (state the journal which has accepted them) may be included. In the text a reference should be cited by author and date; not more than two authors may be cited per reference; if there are more than two authors cite one author and et al. At the end of the manuscript the citations should be typed in alphabetical order, with the authors' surnames and initials inverted. References should include, in the following order: all authors' names, year, journal title, volume number, inclusive page numbers, and name and address of publisher (for books only). The name of the journal should be abbreviated according to the International List of Periodical Title World Abbreviations and underlined to indicate italics. References should therefore be listed (and will subsequently appear in type) as follows):
Hammings J, Arnberg A, Koster H and Gruber M. (1981). Nucleic Acids Res., 9, 1339-1350.
Koster H. (ed). (1980). Nucleic Acids Synthesis: Applications to Molecular Biology and Genetic Engineering. IRL Press: London.
Norris KE, Norris F and Brunfeldt K. (1980). Nucleic Acids Synthesis: Applications to Molecular Biology and Genetic Engineering. Koster H (ed). IRL Press: London, pp. 233-241. Personal communications should be avoided. Manuscripts in preparation or submitted, but not yet accepted, may be cited in the text and should NOT be included in the list of references.
Tables
Tables should be typed on separate sheets and numbered consecutively with Arabic numerals. Tables should be self-explanatory and include a brief descriptive title. Footnotes to tables indicated by lower case letters are acceptable, but they should not include extensive experimental detail.
Illustrations
All illustrations (line drawings and photographs) should be referred to in the text as Figure 1, etc. Write the title of your paper, the name of the first author and the figure number lightly in pencil on the back of each figure. On the manuscript indicate with an arrow in the margin the most appropriate position for the figure.
Photographs Photographs should be of sufficiently high quality with respect to detail, contrast and fineness of grain to withstand some reduction and the inevitable loss of contrast and detail inherent in the printing process. Please indicate the magnification by a rule on the photograph. When several prints of varying quality of the same figure are provided, please indicate which print should be used for reproduction in the journal.
Colour Plates
Inclusion of colour plates will be subject to a special charge.
Line Drawings
Please provide these as clear, sharp prints, suitable for reproduction as submitted.
Figure Legends
These should be on a separate, numbered manuscript sheet. Define all symbols and abbreviations used in the figure.
Style
The journal will broadly but not tenaciously follow the conventions of the Committee of Biological Editors Style Manual (5th edn. 1983). Follow Chemical Abstracts and its indexes for chemical names. For guidance in the use of biochemical terminology follow the recommendations issued by the IUPAC-IUB Commission on Biochemical Nomenclature, as given in Biochemical Nomenclature and Related Documents, published by the Biochemical Society, UK. For enzymes, use the recommended name assigned by the IUPAC-IUB Commission on Biochemical Nomenclature, 1978, as given in Enzyme Nomenclature, published by Academic Press, New York, 1980. Where possible, use the recommended SI (Syste International) units. Genotypes should be italicized (underline in typed copy); phenotypes should not be italicized. For bacterial genetics nomenclature follow Demerec et al. (1986) Genetics, 54, 61-76.
Abbreviations
Try to restrict the use of abbreviations to SI symbols and those recommended by the IUPAC. Abbreviations should be defined in brackets after their first mention in the text. Standard units of measurements and chemical symbols of elements may be used without definition in the body of the paper.
Page Charges
Manuscripts accepted for publication in Oncogene will incur a page charge of ?0 (US $75) per printed page to cover, in part, the cost of publication. Offprint order forms are sent out with the proofs, and must be returned to the publisher. Later orders submitted after the journal is printed are subject to increased prices.
Policy Concerning Availability of Materials
It is understood that by publishing a paper in Oncogene authors agree to make freely available to colleagues in academic research any of the cells, nucleic acids, antibodies, etc that were used in the research reported and that are not available from commercial suppliers.
Business correspondence and enquiries relating to advertising, subscriptions, backnumbers or reprints should be addressed to the relevant person at Nature Publishing Group, Houndmills, Basingstoke, Hampshire RG21 6XS, UK.
Editorial Board
Editors Dr John Jenkins Eden House Enterprise Way Edenbridge Kent TN8 6HF UK Tel: +44 (0) 1732 860111 Fax: +44 (0) 1732 860222 Email: editorial@oncogene.org.uk
Dr E Premkumar Reddy The Fels Institute for Cancer Research and Molecular Biology Medical Research Building 3307 North Broad Street Philadelphia, PA 19140 USA Tel: +1 215 707 4307 Fax: +1 215 707 1454 Email: preddy@assetpublishing.net
Stuart A Aaronson, New York, USA Jerry M Adams, Victoria, Australia Paolo Amati, Rome, Italy Ralph B Arlinghaus, Texas, USA Mariano Barbacid, Madrid, Spain Irvin Chen, Los Angeles, USA Lan Bo Chen, Boston, USA Peter Chumakov, Moscow, Russia Thomas Curran, Memphis, USA Wolfgang Deppert, Hamburg, Germany Giulio Draetta, Milan, Italy Robert Franza, Washington, USA Mitchell Goldfarb, New York, USA Yukiko Gotoh, Tokyo, Japan Andrei V Gudkov, Cleveland, USA Mike J Hayman, Stony Brook, USA Barbara Hoffman, Philadelphia, USA James Ihle, Memphis, USA Yoji Ikawa, Kyoto, Japan Yoshiaki Ito, Singapore Penny Jeggo, Brighton, UK Nicholas Jones, London, UK Peter A Jones, Los Angeles, USA Margaret A Knowles, Leeds, UK Pierre May, Fontenay-aux-Roses, France John Minna, Dallas, USA Kohei Miyazono, Japan Scott A Ness, Albuquerque, USA Nickolai Nickolsky, St Petersburg, Russia Makoto Noda, Kyoto, Japan Masaki Noda, Tokyo, Japan James Pipas, Pittsburgh, USA Terence Rabbitts, Cambridge, UK Varda Rotter, Rehovot, Israel Earl Ruley, Nashville, USA Manfred Schwab, Heidelburg, Germany Bartholomew Sefton, San Diego, USA Karol Sikora, London, UK Dominique Stehelin, Lille, France Yoichi Taya, Tokyo, Japan Masaki Terada, Tokyo, Japan George Vande Woude, Frederick, USA Erwin Wagner, Vienna, Austria Flossie Wong-Staal, San Diego, USA Mitsuaki Yoshida, Tokyo, Japan Editors Dr John Jenkins Eden House Enterprise Way Edenbridge Kent TN8 6HF UK Tel: +44 (0) 1732 860111 Fax: +44 (0) 1732 860222 Email: editorial@oncogene.org.uk
Dr E Premkumar Reddy The Fels Institute for Cancer Research and Molecular Biology Medical Research Building 3307 North Broad Street Philadelphia, PA 19140 USA Tel: +1 215 707 4307 Fax: +1 215 707 1454 Email: preddy@assetpublishing.net
Stuart A Aaronson, New York, USA Jerry M Adams, Victoria, Australia Paolo Amati, Rome, Italy Ralph B Arlinghaus, Texas, USA Mariano Barbacid, Madrid, Spain Irvin Chen, Los Angeles, USA Lan Bo Chen, Boston, USA Peter Chumakov, Moscow, Russia Thomas Curran, Memphis, USA Wolfgang Deppert, Hamburg, Germany Giulio Draetta, Milan, Italy Robert Franza, Washington, USA Mitchell Goldfarb, New York, USA Yukiko Gotoh, Tokyo, Japan Andrei V Gudkov, Cleveland, USA Mike J Hayman, Stony Brook, USA Barbara Hoffman, Philadelphia, USA James Ihle, Memphis, USA Yoji Ikawa, Kyoto, Japan Yoshiaki Ito, Singapore Penny Jeggo, Brighton, UK Nicholas Jones, London, UK Peter A Jones, Los Angeles, USA Margaret A Knowles, Leeds, UK Pierre May, Fontenay-aux-Roses, France John Minna, Dallas, USA Kohei Miyazono, Japan Scott A Ness, Albuquerque, USA Nickolai Nickolsky, St Petersburg, Russia Makoto Noda, Kyoto, Japan Masaki Noda, Tokyo, Japan James Pipas, Pittsburgh, USA Terence Rabbitts, Cambridge, UK Varda Rotter, Rehovot, Israel Earl Ruley, Nashville, USA Manfred Schwab, Heidelburg, Germany Bartholomew Sefton, San Diego, USA Karol Sikora, London, UK Dominique Stehelin, Lille, France Yoichi Taya, Tokyo, Japan Masaki Terada, Tokyo, Japan George Vande Woude, Frederick, USA Erwin Wagner, Vienna, Austria Flossie Wong-Staal, San Diego, USA Mitsuaki Yoshida, Tokyo, Japan
|